Aspirin-induced increase in intestinal paracellular permeability does not affect the levels of LPS in venous blood of healthy women
PhRMA, the industry trade group, argues MFN-style foreign reference pricing would reduce investment and limit access: Importing foreign prices from socialist countries would be a bad deal for American patients and workers, said its CEO Stephen J
Lawyers typically assess damages by reviewing medical records, billing, prognosis, and how the condition changed a persons daily function over time
U wil werken zonder IT-problemen
What clinicians consider when advising against GLP-1 use during breastfeeding Lack of large, controlled lactation safety trials Unknown effects on infant growth or neurodevelopment Uncertainty about effects on milk supply or composition Elective nature of GLP-1 therapy for weight loss Availability of safer alternatives after breastfeeding ends Why FDA and medical guidance remains cautious FDA and specialty guidance emphasize caution during breastfeeding for several consistent reasons: Insufficient data: FDA labeling states there are inadequate data on GLP-1 medication effects in breastfed infants.,, Milk supply unknowns: It is not known whether GLP-1 medications affect milk supply (volume) or milk composition., Infant vulnerability: Early infancy is a sensitive developmental period, increasing caution when medication effects are unknown. Elective vs essential use: For weight management, potential maternal benefit often does not outweigh theoretical infant risk.,, Do semaglutide and tirzepatide pass into breast milk
Sleep, exercise, age and lifestyle play an important role in controlling how fit and lean we are
